Orbimed Advisors sold 860,123 shares of ELVN on June 22, 2026, for approximately $39.0 million at an average price of $45.36 per share. The filing is a routine insider transaction disclosure and does not indicate an operating update or fundamental change. It may modestly affect sentiment around share supply and positioning, but the immediate market impact is likely limited.
Orbimed Advisors sold 860,123 shares of ELVN on June 22, 2026, for approximately $39.0 million at an average price of $45.36 per share. The filing is a routine insider transaction disclosure and does not indicate an operating update or fundamental change. It may modestly affect sentiment around share supply and positioning, but the immediate market impact is likely limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment
